Complete Genomics Launches Cancer Grant Program

MOUNTAIN VIEW, Calif. - Complete Genomics Inc. (NASDAQ: GNOM), a complete human genome sequencing company, today announced that it is introducing a new cancer grant program. Winning research applications will receive complete human genome sequencing of eight genomes — four tumor/normal pairs. Four winning entries will be chosen: two each from the United States and [...]

BD Biosciences Introduces Chemically Defined Cell Culture Media Supplement that Increases Biopharmaceutical Protein Production

Baltimore, MD – BD Biosciences, a segment of BD (Becton, Dickinson and Company), announced today the availability of BD Recharge™, a chemically defined (CD) cell culture media supplement for biopharmaceutical manufacturing that offers productivity comparable to yeast-based peptones. “Chemically defined supplements are a significant advance for biopharmaceutical cell culture,” said Robert Hallenbeck, Vice President, BD [...]

Investigating protein-binding properties of Heparin, Heparan Sulfate and other glycosaminoglycans (GAGS)

AMSBIO has announced a suite of exciting new products for investigating the protein-binding properties of Heparin, Heparan Sulfate (HS) and other glycosaminoglycans (GAGS). Such investigations have traditionally been constrained by the need for chemical modification prior to attachment to inert or derivatized surfaces. The AMSBIO Heparin/GAG Binding Plate offers a simple solution to this problem [...]

Boreal Genomics Announces the Appointment of Nitin Sood to CEO

Vancouver, BC, Canada – Boreal Genomics, the developer of the SCODA nucleic acid purification and sequence specific target enrichment technology, announced today that Nitin Sood has been appointed Chief Executive Officer and member of the company’s Board of Directors. Sood joins founder and Chief Scientific Officer, Dr. Andre Marziali, who will continue serving as a [...]

High throughput EHEC Pathogen Examination of Stool Samples using Roche´s MagNA Pure 96 and LightCycler® Systems

Penzberg, Germany - During the last weeks, there has been a significant increase in the number of cases of bloody diarrhea associated with hemolytic-uremic syndrome (HUS) caused by enterohaemorrhagic Escherichia coli (EHEC). To date, more than 3,400 laboratory confirmed EHEC and HUS cases have been reported, 39 of them with fatal outcome (Robert Koch Institute’s [...]

AB SCIEX Aids Food Testing Laboratories’ Response to Rising Concerns About the Latest Wave of Food Contamination

Framingham - In light of widespread recalls of potentially harmful phthalate-tainted food and beverage products in Asia, AB SCIEX, a global leader in life science analytical technologies, is responding by equipping food safety investigators with a new method designed to accurately identify the harmful plasticizer chemical recently found in some clouding agents, which are commonly [...]

Leading Biomedical Researchers Develop New Approach for Protein Quantification with AB SCIEX QTRAP Technology

Framingham - AB SCIEX, a global leader in life science analytical technologies, today announced that a group of Ontario-based scientists, including Kyoto Prize-winning Tony Pawson, Ph.D., and Nicolas Bisson, Ph.D., at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital, have developed a new approach for protein quantification based on QTRAP® and Eksigent technologies with [...]

BioTime Announces Appointment of Chief Commercial Officer

ALAMEDA, Calif. - BioTime, Inc. /quotes/zigman/219441/quotes/nls/btx BTX -3.74% today announced the appointment of its Vice President of Business Development, William P. Tew, Ph.D., to the additional position of Chief Commercial Officer. Dr. Tew will be responsible for the commercial operations of the BioTime family of companies and for near-term product development activities. Dr. Tew's commercial [...]

International Stem Cell’s Lifeline Cell Technology Subsidiary Expands Sales and Distribution While Enhancing Manufacturing Capability and Clinical Product Opportunities

CARLSBAD, Calif. - International Stem Cell Corporation (OTCBB:ISCO) (www.intlstemcell.com), the first company to perfect a method of creating human “parthenogenetic” stem cells derived from unfertilized human eggs, reports that its wholly owned subsidiary, Lifeline Cell Technology (Lifeline), grew 2011 first quarter product sales by 35% and gained well over 200 new customers compared with the [...]

American Science and Engineering, Inc. Awarded an IDIQ Contract from the DoD with a Potential Value Up To $248.5 Million

BILLERICA, Mass. - American Science and Engineering, Inc. (AS&E) (NASDAQ:ASEI), a leader in X-ray detection technology, announced that the Company has been awarded an indefinite delivery/ indefinite quantity (IDIQ) contract from the Department of Defense (DoD) for ruggedized Non-Intrusive Inspection (NII) systems for personnel and cargo screening, and Entry Control Point (ECP) Hardware Sets for [...]

Access IBO on Knowledge Center